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Recently several endogenous epidermal growth factor
(EGF)-family growth factors (transforming growth
factor-a, amphiregulin, and heparin-binding EGF-like
growth factor) have been identified in human keratino-
cytes. These factors are known to play an important role
in the regulation of cell proliferation. Here we show that
the interaction between these factors and EGF receptor
are key factors in the progression from the G1 phase to the
S phase (the G1/S progression) in human keratinocytes. In
this study, human keratinocytes were cultured in serum-
free MCDB153 medium and then partially synchronized
by isoleucine deprivation. After synchronization, the
number of S phase cells increased and reached a maxi-
mum after 18–24 h. The immediate addition of anti-EGF
receptor blocking antibody (1 mg per ml) to synchronized
cells decreased S phase cells by 42.5% compared with
The progression of the cell cycle can be regulated eitherat control points in the G1 phase that precedes the Sphase or at points in the G2 phase prior to mitosis.Thus, progression from the G1 to the S phase (the G1/S progression) is a crucial step in the cell cycle. In order
to study the G1/S progression, synchronized populations of cells are
required. We adapted the isoleucine-deprivation method for cell
synchronization to normal human keratinocytes (Ashihara and Baserga,
1979; Ayusawa, 1992; Kobayashi et al, 1998), because (i) this method
exerts little or no effect on the metabolic processes of the cell, and
(ii) it enables us to harvest synchronized cells in large quantities. This
method allowed us to study in greater detail the cell cycle of normal
human keratinocytes in culture.
Recent studies have shown that human keratinocytes produce
endogenous epidermal growth factor (EGF)-family growth factors
such as transforming growth factor-α (TGF-α) (Coffey et al, 1987),
amphiregulin (AR) (Shoyab et al, 1989; Cook et al, 1991), and heparin-
binding EGF-like growth factor (HB-EGF) (Higashiyama et al, 1991;
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untreated keratinocytes at 18 h. By contrast, the addition
of anti-EGF receptor antibodies at 12 h or later did not
alter the percentage of S phase cells. Northern blot
analysis of synchronized cells demonstrated that mRNA
expression of transforming growth factor-a, amphiregu-
lin, heparin-binding EGF-like growth factor, and EGF
receptor reached a maximum within 0.5–3 h after syn-
chronization, when many cells initiated progression from
the G1 to the S phase. The results show that anti-EGF
receptor antibodies block the G1/S progression and the
rapid increase of mRNA expression of endogenous EGF-
family growth factors and EGF receptor during G1/S
progression. These findings indicate that growth factor
binding and EGF receptor activation are involved in the
G1/S cell cycle progression of human keratinocytes.
Key words: cell cycle/EGF receptor/synchronization. J Invest
Dermatol 111:616–620, 1998
Hashimoto et al, 1994). In human keratinocytes, TGF-α is synthesized,
and its production is induced by EGF and TGF-α (auto-induction
mechanism) (Coffey et al, 1987). AR competes with EGF for cell
surface binding, exerts at least some of its biologic effects through the
EGF receptor (EGFR), and, thus, represents an autocrine growth factor
for keratinocytes (Shoyab et al, 1988, 1989; Cook et al, 1991). HB-
EGF is another new member of the EGF family that was initially
purified from conditioned medium of the U-937 macrophage-like cell
line (Higashiyama et al, 1991). HB-EGF and AR share structural
characteristics (Higashiyama et al, 1992). A recent report has shown
that HB-EGF is an autocrine growth factor for human keratinocytes
(Hashimoto et al, 1994).
These factors display equivalent affinity for EGFR in an intestinal
epithelial cell line (Barnard et al, 1994). The EGFR is a 170 kDa
transmembrane glycoprotein consisting of an extracellular binding
domain and an intracellular domain that exhibits tyrosine kinase activity.
The binding of physiologic ligands to the external domain of the
receptor stimulates tyrosine kinase activity and promotes the activation
of other signaling molecules such as phospholipase C, phosphatidylinosi-
tol 3-kinase, and mitogen-activated protein kinase. Ultimately, activa-
tion of the EGFR leads to mitosis (Blenis, 1993). EGF, TGF-α, and
EGFR play an important role in the growth regulation of many normal
and malignant cell types (Ennis et al, 1989; Bates et al, 1990; Crew
et al, 1992; Dong et al, 1992; Rabiasz et al, 1992).
Monoclonal anti-EGFR neutralizing antibody (aEGFR) blocks bind-
ing of EGF-family growth factors to the receptor, inhibits cellular
proliferation, and provides a tool to examine cell cycle regulation in
keratinocytes (Sunada et al, 1986; Ennis et al, 1989, 1991; Pittelkow
et al, 1993), similar to several other cell types where proliferation is
inhibited (Kawamoto et al, 1983; Sato et al, 1983; Ennis et al, 1989;
Bates et al, 1990; Pittelkow et al, 1993).
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Here we show that the interaction between EGFR and endogenous
EGF-family growth factors plays an important role in the G1/S
progression of synchronized keratinocytes.
MATERIALS AND METHODS
Cell culture and synchronizaton Normal human keratinocytes were cul-
tured as described previously (Wille et al, 1984). Briefly, skin was cut into pieces
3–5 mm square, and floated on dispase solution (500 U per ml) overnight at
4°C. After separation of epidermis from dermis by forceps, the epidermal sheets
were rinsed with Ca21 and Mg21-free phosphate-buffered saline and incubated
in 0.25% trypsin solution for 10 min at 37°C, and then the epidermis was
teased free by forceps. Cells were suspended and cultured in MCDB153
medium (Kyokuto, Tokyo, Japan) supplemented with insulin (5 µg per ml),
hydrocortisone (5 3 10–7 M), ethanolamine (0.1 mM), phosphoethanolamine
(0.1 mM), and bovine hypothalamic extract (150 µg per ml) (‘‘complete’’
MCDB153 medium). EGF was not added. Second-passage cells were used for
synchronization. The growing cells were synchronized by transfer to MCDB153
medium deprived of isoleucine, insulin, hydrocortisone, and bovine hypo-
thalamic extract. After 60 h, they were detached from the dish by trypsin
treatment and were replated in complete MCDB153 medium.
Cell cycle analysis The cell cycle analysis of human keratinocytes was
performed by the two color cell cycle analysis method (Dolbeare et al, 1983).
Synchronized cells were pulse-labeled with 0.01 mM 5-bromodeoxyuridine for
120 min prior to each time point. 5-Bromodeoxyuridine incorporated into
the nucleus was immunochemically stained using anti-5-bromodeoxyuridine
monoclonal antibody (Becton Dickson, San Jose, CA), and DNA was stained
with propidium iodide. These stained cells were analyzed by flow cytometry
using a FACScan (Becton Dickson). Ten thousand cells were used for each
FACScan analysis.
Blocking by aEGFR aEGFR (Ab-3; Oncogene Research Products,
Calbiochem-Novabiochem International, San Diego, CA) is a mouse mono-
clonal antibody (IgG1) produced by immunization of mice with partially
purified EGFR from A431 cells. aEGFR binds to A431, HeLa cells, and other
human cells. It inhibits ligand binding to receptor and acts as an antagonist of
EGF-stimulated tyrosine kinase activity (Gill et al, 1984; Kawamoto et al, 1984).
The antibody was used at 1 µg per ml in these experiments. This concentration
is enough to inhibit cell growth in complete MCDB153 medium (Inui et al,
1997). Normal preimmune mouse IgG at the same concentration was used
as control.
Northern blot analysis Total RNA from cultured human keratinocyte
was prepared by the acid guanidium thiocyanate/phenol/chloroform method
(Chorriczynski and Sacchi, 1987‘). Twenty micrograms of total RNA per lane
was fractionated on a 1.8% formaldehyde-agarose gel and transferred to
GeenScreen (DuPont NEN, Boston, MA) in 20 3 sodium citrate/chloride
buffer (150 mM sodium chloride, 15 mM sodium citrate) according to standard
procedure (Sambrook et al, 1989). Ultraviolet cross-linking was performed by
ultraviolet radiation in a Stratalinker (Stratagene, La Jolla, CA). Prehybridization
was carried out in sealed plastic bags for 6 h at 65°C in a hybridization buffer
(5 3 sodium citrate/chloride buffer, 10 3 Denhardt’s solution, 10 mM
NaHPO4, pH 6.5, 0.5% sodium dodecyl sulfate, 50% formamide, 0.1 mg
sonicated herring sperm DNA per ml). Hybridization was performed using
hybridization buffer supplemented by 1000 ng of digoxigenin (DIG)-labeled
single-stranded RNA probe per ml of buffer for 16 h at 65°C. The hybridized
filters were then washed at 65°C once in 2 3 sodium citrate/chloride buffer,
0.1% sodium dodecyl sulfate, and twice in 0.2 3 sodium citrate/chloride buffer,
0.1% sodium dodecyl sulfate.
DIG-labeled nucleic acids were detected in the following way (During, 1991;
Lanzillo, 1991). All the steps were carried out at room temperature. Reagents
were a part of the Boehringer DIG DNA detection kit. The filter was briefly
rinsed twice in DIG buffer 1 (0.1 M maleic acid, 0.15 M NaCI, pH 7.5), and
subsequently nonspecific binding sites were blocked by incubating them for
60 min in DIG buffer 1 containing 1.5% (wt/vol) Boehringer blocking regent,
a specially purified fraction of dried milk powder.
Anti-DIG Fab fragment, conjugated to alkaline phosphatase diluted 1:10,000
in DIG buffer 1 containing 0.2% Tween 20, was applied for 30 min. Excess
antibody was washed off twice in DIG buffer 1 containing 0.2% Tween 20 for
20 min, and this buffer was then exchanged for DIG buffer 3 (0.1 M Tris-
HCI, 0.1 M NaCl, 50 mM MgCl2, pH 9.5) for 3 min. The filter was washed
twice with the assay buffer (100 mM diethanolamine, 2 mM MgCl2, 0.02%
NaN3) for 10 min and then incubated with 3-(29-spiroadamantane)-4-methoxy-
4-(39-phosphoryloxy)-phenyl-1,2-dioxetane solution (0.1 mg per ml in the
assay buffer) in a plastic bag for 15 min as described elsewhere. The filter was
then transferred and sealed in a new plastic bag and exposed to Kodak X-Omat
AR film at room temperature for periods ranging from 30 min to 2 h. For all
Figure 1. Time-dependent change in the percentage of each cell cycle
phase in synchronized human keratinocytes. Percentage of each cell cycle
phase was measured every 3 h up to 30 h. Synchronized cells were pulse labeled
with 0.01 mM 5-bromodeoxyuridine for 120 min prior to each time point.
Cell cycle distribution was analyzed by flow cytometry, using a FACScan. Data
represent the mean 6 SD of triplicate measurements at 0, 6, 9, 12, and 18 h.
Maximal increase was observed at 18–24 h after stimulation of cell growth.
Experiments were performed at least five times.
of the northern blots, the rRNA (28 and 18 S) in the gels was stained with
ethidium bromide and photographed before being transferred to a nylon
membrane to confirm the presence of equivalent amounts of RNA in each
lane. The relative signal intensities of mRNA levels were quantitated by
densitometric scanning using a dual wavelength flying spot scanner (CS-9000;
Shimadzu, Tokyo, Japan).
RESULTS
Cell cycle phase enrichment following synchronization We
evaluated cell cycle synchronization using flow cytometry. Second-
passage cells were cultured in complete MCDB153 medium for
several days. Cells were switched to an isoleucine-deprived MCDB153
medium for 60 h, as described in Materials and Methods. This treatment
decreased the percentage of cells in the S phase from 32.0 6 3.7% to
4.2 6 1.0% and increased the cell percentage in the G1/G0 and
G2 1 M phases from 49.1 6 4.3% to 68.2 6 4.4% and from
18.9 6 2.7% to 27.6 6 4.7%, respectively. Cells preferentially arrest
in the G1/G0 phase.
Next, we examined the change of cell cycle distribution over time
after cells were replated in complete MCDB153 medium following
isoleucine-deprivation. Cell cycle distribution was measured every 3 h
up to 30 h (Fig 1). The percentage of cells in the S phase remained
ø 2% until 6 h, when the S phase percentage started to increase. The
peak percentage of 28.1 6 5.5% was reached at 18 h and then started
to decrease again after 24 h. Concomitantly, the cell percentage in the
G1/G0 phase decreased from 64.9 6 4.2% at 0 h to a low point of
36.6% at 24 h, and then started to increase. The percentage in G2 1 M
was 31.3 6 4.1% at 0 h and increased gradually over time.
aEGFR inhibits S phase progression early in cell cycle progres-
sion of synchronized keratinocytes Immediate addition of aEGFR
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Figure 2. Effect of aEGFR on the percentage of S phase cells in
synchronized human keratinocytes. Cell cycle distribution was analyzed by
flow cytometry, using a FACScan. Cells were harvested at 0 h and 18 h after
switching from leucine-deficient to complete medium and adding aEGFR.
aEGFR (1) and (–) refer to cells treated or not treated with aEGFR (1 µg per
ml). Mouse IgG (1 µg per ml) was added as control in aEGFR(–). Bars represent
the mean and SD of triplicate measurements. Experiments were repeated three
times. *Statistically significant values (p , 0.01). The p value was calculated
using the Student t test.
(1 µg per ml) following synchronization decreased S phase cells by
42.5%, compared with untreated keratinocytes at 18 h (Fig 2). By
contrast, the addition of aEGFR at 12 h or later after switching to
complete medium did not alter the percentage of S phase cells (data
not shown). We next examined expression of EGF-related ligands and
EGFR during keratinocyte cell cycle progression.
Effects on mRNA expression of endogenous EGF-family
growth factors (TGF-a, AR, and HB-EGF) We analyzed the
time-dependent mRNA expression of EGF-family growth factors
(TGF-α, AR, and HB-EGF) by northern blot analysis and densitometry
(Fig 3). mRNA expression was examined at 0.5, 1, 3, 6, 21, and 33 h
after replating in complete medium. Maximum expression of all ligands
was observed after between 0.5 and 3 h.
Levels of TGF-α mRNA increased slowly following synchronization
and release, compared with AR and HB-EGF. Peak expression was
observed between 1 h (2.3-fold) and 3 h (2.2-fold), followed by a
marked decrease in level of expression.
The increase in levels of AR mRNA was the most marked. The
maximum level was reached between 30 min (2.2-fold) and 1 h (2.6-
fold). By 3 h, the AR mRNA level decreased to baseline level.
HB-EGF mRNA levels changed the least. An increase of only 1.9-
fold at 30 min and of 1.8-fold at 1 h was observed, followed by a
gradual decrease over time.
Increased expression of these EGF-related growth factors preceded
the cell cycle progression of the synchronized and reflected cells.
Alterations in mRNA expression of EGFR We analyzed and
quantitated the levels of mRNA expression of EGFR by northern blot
and densitometry (Fig 4). mRNA expression of EGFR was examined
at 0.5, 1, 3, 6, 21, and 33 h after release from synchronization.
EGFR mRNA did not show the more marked changes observed
for mRNA levels of the EGF-related ligands, and increased only 1.4,
1.5, and 1.3-fold at 30 min, 1 h, and 3 h, respectively. EGFR mRNA
Figure 3. Time-dependent change in mRNA expression levels of TGF-a,
AR, and HB-EGF in synchronized keratinocytes. mRNA expression of
(a) TGF-α, (b) AR, and (c) HB-EGF was analyzed at 0.5, 1, 3, 6, 21 and 33 h
by northern blot analysis. (d) rRNA (28 and 18 S) was stained with ethidium
bromide. This analysis was performed with 20 µg of RNA per lane. For each
experiment, equal loading of RNA was confirmed by ethidium bromide
staining. (e) Densitometric analysis; relative intensity of mRNA expression of
each growth factor, with mRNA at 0 h shown as 100. s, TGF-α; u, AR;
n, HB-EGF.
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Figure 4. Time-dependent change in mRNA expression levels of EGFR
in synchronized keratinocytes. (a) mRNA expression of EGFR was analyzed
at 0.5, 1, 3, 6, 21, and 33 h by northern blot analysis. (b) rRNA (28 and 18 S)
was stained with ethidium bromide. This analysis was performed with 20 µg
of RNA per lane. Equivalence of RNA loading in each lane was confirmed
by ethidium bromide staining. (c) Densitometric analysis; relative intensity of
EGFR mRNA, with mRNA at 0 h shown as 100.
levels subsequently decreased markedly to one half the initial level at
21 h, at a time when the percentage of S phase cells were maximal.
DISCUSSION
In this report, we demonstrate that the interaction between EGFR
and endogenous EGF-family growth factors plays an important role in
the G1/S progression of synchronized keratinocytes.
The discovery of several new EGF-family growth factors has made
it more challenging to understand the mechanisms of cell cycle
regulation and growth factor interactions in keratinocytes that express
these ligands. Previous work (Coffey et al, 1987) identified upregulation
of TGF-α mRNA and protein by EGF, and described the phenomenon
of autoregulation of TGF-α gene expression in cultured keratinocytes.
Other studies (Barnard et al, 1994; Hashimoto et al, 1994) have reported
the cross-regulation of EGF-family growth factor gene expression by
these same factors in several epithelial cell types, suggesting complexity
in the molecular mechanisms that are involved in induction of
these factors. Therefore, these growth factors may act not only by
autoinduction but also through mutual amplification mechanisms. By
contrast, it has been recently reported that inhibition of ligand binding
and kinase activation of EGFR in keratinocytes is coupled to growth
arrest, cell commitment, and induction of terminal differentiation (Peus
et al, 1997). These findings point to EGFR in regulating growth
control mechanisms as well as the expression of endogenous EGF-
related ligands that mediate cell cycle progression in keratinocytes.
We have shown that the addition of aEGFR inhibited the increase
of S phase cells of keratinocytes synchronized in serum- and growth
factor-free culture medium. This observation implicates a role for
EGFR and endogenous ligands in G1/S progression of keratinocytes.
We also examined the levels of mRNA expression of endogenous
EGF-related ligands (TGF-α, AR, and HB-EGF). Though the mRNA
levels of each of these ligands increased during G1/S progression, the
profile of change for each was distinct. As can be seen in Fig 3(e),
AR and HB-EGF increased during the early phase, and HB-EGF
tended to decrease quickly at 1 h. At 1 h, AR further increased and
TGF-α expression began to increase. At 3 h, AR and HB-EGF
declined to base line levels. We speculate from these results that AR
and HB-EGF may play important roles in the early stages of G1/S
progression. TGF-α continued to increase to over twice the initial
level at 3 h. TGF-α may play a role in sustaining G1/S progression
that has been initiated by AR and HB-EGF.
Barnard et al have drawn similar conclusions regarding the status of
AR and HB-EGF as immediate early genes (Barnard et al, 1994). They
have reported that AR and HB-EGF were rapidly and intensely
induced by EGF-family growth factor treatment, and that the induction
occurred through a transcriptional mechanism. Our studies show that
AR and HB-EGF may be regarded as an immediate early gene in the
G1/S progression; however, it is still unclear why keratinocytes express
these EGF-family growth factors. We hypothesize that the cooperation
of HB-EGF, AR, and TGF-α in a time-dependent manner make it
possible for keratinocytes to progress from the G1 to the S phase.
We also considered the possibility that the relative expression of
EGFR could regulate the G1/S progression in conjunction with
expression of the cognate ligands. EGFR mRNA increased slightly in
the early phases; however, the level of mRNA expression declined to
one half the initial level at 21 h (when S phase cells were maximum),
at a time when the EGF-related ligands had also decreased. These
results indicate that EGFR–endogenous ligand interactions might not
be required at later times once the cell has entered the S phase.
There are few reports that have identified any cell cycle regulatory
proteins upon which EGF-family growth factors act. Recently it
has been shown that the growth of HPV 16-immortalized human
keratinocytes can be blocked by a selective EGFR kinase inhibitor,
which induces a significant increase in the Cdk2 protein inhibitors
p27 and p21, and counteracts the activation of Cdk2 (Ben-Bassat
et al, 1997).
The EGFR-endogenous EGF-related ligand interactions are critical
regulators of the keratinocyte cell cycle. Further investigations are
necessary to fully elucidate the complex mechanisms involved in
autocrine growth and differentiation control of keratinocytes and
epidermis. These findings demonstrate a role for endogenous EGF-
related ligands and the relevant receptor, EGFR, in controlling G1/S
cell cycle progression.
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